Skip to main content
logo
CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
76.51
-1.74 (-2.22%)
Sep 22, 2026, 12:48 PM EDT - Market open

CG Oncology Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
6.234.041.140.20.1910.36
Revenue Growth
1030.31%254.70%458.33%6.81%-98.16%-
Gross Profit
-161.54-117.25-80.96-45.55-28.84-7.96
Operating Income
-252.62-190.77-114.67-55.45-35.25-12.61
Net Income
-224.38-161-88.04-67.8-43.79-18.38
Earnings Per Share
-2.72-2.08-1.41-15.65-11.71-5.04
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,028742.16742187.67143.4853.61
Total Debt
8.827.020.240.4615.9415.13
Net Cash (Debt)
1,019735.13741.76187.21127.5438.48
Net Cash Growth
54.45%-0.89%296.21%46.79%231.45%-
Net Cash Per Share
12.379.5111.8743.2334.0910.54

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-178.47-132.35-78.71-45.68-29.8-13.65
Capital Expenditures
-0.88-0.13-0.23--0.01-0.1
Free Cash Flow
-179.34-132.48-78.95-45.68-29.82-13.75
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------76.86%
Operating Margin
-4056.18%-4722.13%-10067.25%-27180.88%-18453.40%-121.70%
Pretax Margin
-3602.68%-3985.02%-7729.50%-23826.96%-18556.54%-123.95%
Profit Margin
-3602.68%-3985.03%-7729.50%-33234.31%-22925.65%-177.48%
FCF Margin
-2879.62%-3279.21%-6931.26%-22391.67%-15611.52%-132.76%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1120.81829.031916.94---